1. Home
  2. CRBU vs BLNK Comparison

CRBU vs BLNK Comparison

Compare CRBU & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • BLNK
  • Stock Information
  • Founded
  • CRBU 2011
  • BLNK 2009
  • Country
  • CRBU United States
  • BLNK United States
  • Employees
  • CRBU N/A
  • BLNK N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • BLNK Industrial Specialties
  • Sector
  • CRBU Health Care
  • BLNK Consumer Discretionary
  • Exchange
  • CRBU Nasdaq
  • BLNK Nasdaq
  • Market Cap
  • CRBU 93.0M
  • BLNK 105.2M
  • IPO Year
  • CRBU 2021
  • BLNK N/A
  • Fundamental
  • Price
  • CRBU $0.74
  • BLNK $0.68
  • Analyst Decision
  • CRBU Strong Buy
  • BLNK Buy
  • Analyst Count
  • CRBU 5
  • BLNK 8
  • Target Price
  • CRBU $11.80
  • BLNK $3.19
  • AVG Volume (30 Days)
  • CRBU 1.1M
  • BLNK 3.7M
  • Earning Date
  • CRBU 05-06-2025
  • BLNK 05-08-2025
  • Dividend Yield
  • CRBU N/A
  • BLNK N/A
  • EPS Growth
  • CRBU N/A
  • BLNK N/A
  • EPS
  • CRBU N/A
  • BLNK N/A
  • Revenue
  • CRBU $9,994,000.00
  • BLNK $126,197,000.00
  • Revenue This Year
  • CRBU N/A
  • BLNK $2.17
  • Revenue Next Year
  • CRBU $163.34
  • BLNK $32.64
  • P/E Ratio
  • CRBU N/A
  • BLNK N/A
  • Revenue Growth
  • CRBU N/A
  • BLNK N/A
  • 52 Week Low
  • CRBU $0.66
  • BLNK $0.63
  • 52 Week High
  • CRBU $4.21
  • BLNK $3.75
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 34.01
  • BLNK 31.04
  • Support Level
  • CRBU $0.71
  • BLNK $0.66
  • Resistance Level
  • CRBU $0.94
  • BLNK $0.78
  • Average True Range (ATR)
  • CRBU 0.10
  • BLNK 0.08
  • MACD
  • CRBU 0.00
  • BLNK -0.01
  • Stochastic Oscillator
  • CRBU 23.44
  • BLNK 16.08

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About BLNK Blink Charging Co.

Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.

Share on Social Networks: